AVIR Completes Enrollment
Atea Pharmaceuticals completes patient enrollment in Phase 3 C-FORWARD trial for Hepatitis C treatment
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.